Anthrax as a Biological Weapon: Medical and Public Health Management
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Anthrax as a Biological Weapon: Medical and Public Health Management

Thomas V. Inglesby;Donald A. Henderson;John G. Bartlett;Michael S. Ascher;Edward Eitzen;Arthur M. Friedlander;Jerome Hauer;Joseph McDade;Michael T. Osterholm;Tara O'Toole;Gerald Parker;Trish M. Perl;Philip K. Russell;Kevin Tonat;for the Working Group on Civilian Biodefense;
JAMA 1999 Vol. 281 pp. 1735-1745
222
inglesby1999jamaanthrax

Abstract

Objective To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population. Participants The working group included 21 representatives from staff of major academic medical centers and research, government, military, public health, and...

Keywords

public health medicine (field) anthrax disease biological warfare agents post-exposure prophylaxis

Access

URL:
http://dx.doi.org/10.1001/jama.281.18.1735

Citation

ID: 114185
Ref Key: inglesby1999jamaanthrax
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114185
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store